Concepedia

Modus Therapeutics (Sweden)

MT

Statistics

Publications

50

Citations

1.3K

Authors

7

Location

Stockholm, Sweden

Also known as Dilafor

Modus Therapeutics (Sweden) is a company institution in Stockholm, Sweden known for pharmacology, medicine, and heparin-protein interactions.

HomepageROR

Top concepts

Publications

50

Release of Sequestered Malaria Parasites upon Injection of a Glycosaminoglycan

Anna M. Vogt, Fredrik Pettersson, Kirsten Moll et al. · PLoS Pathogens · 2006 · 113 citations · Full text

, , +17

Outdoor navigation with a spherical amphibious robot

Viktor Kaznov, M Seeman · 2010 · 77 citations

, , +17

Inhibition of merozoite invasion and transient de-sequestration by sevuparin in humans with Plasmodium falciparum malaria

Anna M. Leitgeb, Prakaykaew Charunwatthana, Ronnatrai Rueangveerayut et al. · PLoS ONE · 2017 · 53 citations · Full text

, , +17

Sevuparin binds to multiple adhesive ligands and reduces sickle red blood cell‐induced vaso‐occlusion

Marilyn J. Telen, Milena Batchvarova, Siqing Shan et al. · British Journal of Haematology · 2016 · 50 citations · Full text

, , +17

A fluorescent probe assay (Heparin Red) for direct detection of heparins in human plasma

Ulrich Warttinger, C. Giese, Job Harenberg et al. · Analytical and Bioanalytical Chemistry · 2016 · 48 citations

, , +11

1–5 of 50

Authors

7

  1. MS
    M Seeman

    Modus Therapeutics (Sweden), Sweden

    26 publications · 181 citations

    8

    h-index

  2. MA
    Mert Aral

    Modus Therapeutics (Sweden), Sweden

    5 publications · 607 citations

    3

    h-index

  3. ED
    Ellen Donnelly

    Modus Therapeutics (Sweden), Sweden

    2 publications · 46 citations

    2

    h-index

  4. AA
    Alibülent Antmen

    Modus Therapeutics (Sweden), Sweden

    1 publications · 38 citations

    1

    h-index

  5. GU
    Gabriel Ukala

    Modus Therapeutics (Sweden), Sweden

    1 publications · 38 citations

    1

    h-index

1–5 of 7